• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Chugai in-licenses RNAi therapeutic zilebesiran for hyp.high cardiovascular risk

    PHARMABIZ

    Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran

    BUSINESSWIRE

    Alnylam to Webcast to Discuss Results from KARDIA-2 Phase 2 Study of Zilebesiran

    BUSINESSWIRE

    Roche, Alnylam say blood pressure drug succeeds in mid-stage trial

    BIOPHARMA DIVE

    Alnylam Reports Positive Results from Phase 2 Dose-Ranging Study of Zilebesiran

    BUSINESSWIRE

    Roche enters partnership with Alnylam for hypertension therapy

    REUTERS

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.